Unit of Shoulder Surgery Romagna/ Cervesi Hospital, Italy
Welcome,         Profile    Billing    Logout  
 9 Trials 
18 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Martinez, Fernando
AZ-SWED, NCT04669288: AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department

Terminated
3
840
US
Azithromycin, Placebo
University of Arizona, University of Utah, Emory University, Morgan Stanley Children's Hospital, University of Pittsburgh, Children's Hospital and Health System Foundation, Wisconsin, Children's Hospital of Philadelphia, Children's Hospital Medical Center, Cincinnati, Boston Children's Hospital
Asthma, Wheezing
12/24
01/25
PRECISIONS, NCT04300920: Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection () Trial

Active, not recruiting
3
202
US
N-acetyl cysteine, NAC, Placebo
Weill Medical College of Cornell University, University of Virginia, University of Michigan, Pulmonary Fibrosis Foundation, University of Washington, National Heart, Lung, and Blood Institute (NHLBI), Three Lakes Foundation
Idiopathic Pulmonary Fibrosis
02/26
02/26
PILLAR, NCT04636814 / 2020-003648-97: A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis.

Recruiting
3
3980
Europe, US, RoW
CHF6001 1600µg, CHF6001 3200µg, Placebo, Roflumilast
Chiesi Farmaceutici S.p.A., Chiesi Farmaceutici S.p.A.
Chronic Obstructive Pulmonary Disease
09/27
09/27
ORBEX, NCT02148796: Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness

Active, not recruiting
2
822
US
Broncho-Vaxom (BV), OM-85 BV VEGETAL, Broncho-Vaxom concentrate (bacterial lysate), Placebo
University of Arizona
Asthma, Wheezing
12/25
12/25
NCT06265532: Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

Recruiting
1
22
US
EGCG 300 mg, Dietary Supplement: EGCG Capsules with EGCG (at least 94% purity). 300 mg EGCG (2 capsules) taken orally daily for 12 weeks., Placebo for EGCG 300 mg, Dietary Supplement: Placebo Placebo (2 capsules) taken orally daily for 12 weeks., EGCG 600 mg, Dietary Supplement: EGCG Capsules with EGCG (at least 94% purity). 600 mg EGCG (4 capsules) taken orally daily for 12 weeks., Placebo for EGCG 600 mg, Dietary Supplement: Placebo Placebo (4 capsules) taken orally daily for 12 weeks.
Hal Chapman, Cornell University, Massachusetts General Hospital, University of Michigan, National Heart, Lung, and Blood Institute (NHLBI)
Idiopathic Pulmonary Fibrosis
03/26
03/26
NCT05195918: Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

Recruiting
1
50
US
EGCG 300 mg + Nintedanib, epigallocatechin-3-gallate + Ofev, EGCG 300 mg + Pirfenidone, epigallocatechin-3-gallate + Esbriet, Placebo 2 capsules + Nintedanib or Pirfenidone, Placebo + Ofev or Esbriet, EGCG 600 mg + Nintedanib, EGCG 600 mg + Pirfenidone, Placebo 4 capsules + Nintedanib or Pirfenidone
Hal Chapman, University of Michigan, Cornell University, Massachusetts General Hospital, Temple University, University of Washington, University of Virginia
Idiopathic Pulmonary Fibrosis
04/26
04/26
CAPTURE, NCT03583099: The Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

Completed
N/A
2004
US
COPD plus CAPTURE education and patient-level information, COPD Education Only
Weill Medical College of Cornell University, National Heart, Lung, and Blood Institute (NHLBI), University of Michigan, National Jewish Health, Wake Forest University Health Sciences, Duke University, High Plains Research Network, L.A. Net Community Health Resource Network, Oregon Health and Science University, University of Kentucky, University of Minnesota, COPD Foundation
Chronic Obstructive Pulmonary Disease (COPD)
04/23
04/23
NCT04543461: American Lung Association (ALA) Lung Health Cohort

Recruiting
N/A
4000
US
Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI), American Lung Association, Stanford University
Lung Diseases
09/26
09/26
NCT06371833: PRIMA EU Retrospective & Prospective

Recruiting
N/A
60
Europe
Shoulder Arthroplasy with PRIMA humeral stem
Limacorporate S.p.a, Iqvia Pty Ltd
Arthroplasty, Replacement, Shoulder
12/26
12/26
SOURCE, NCT05033990: SPIROMICS Study of Early COPD Progression

Recruiting
N/A
1000
US
Weill Medical College of Cornell University, National Heart, Lung, and Blood Institute (NHLBI), University of North Carolina, Chapel Hill, Columbia University, Johns Hopkins University, National Jewish Health, University of Alabama at Birmingham, University of California, Los Angeles, University of Illinois at Chicago, University of Iowa, University of Michigan, University of Utah, Wake Forest University Health Sciences, Temple University, University of California, San Francisco, COPD Foundation, Mayo Clinic
COPD, Early-Onset
01/25
04/25
Castagna, Alessandro
Stemshoulder, NCT04308213: Study on Shoulder Arthritis Treatment With Intra-articular Injections of Autologous Bone Marrow Aspirate.

Recruiting
N/A
30
Europe
Marrow Cellution System
Istituto Clinico Humanitas
Shoulder Arthritis
04/24
09/24
NCT06371833: PRIMA EU Retrospective & Prospective

Recruiting
N/A
60
Europe
Shoulder Arthroplasy with PRIMA humeral stem
Limacorporate S.p.a, Iqvia Pty Ltd
Arthroplasty, Replacement, Shoulder
12/26
12/26
Paladini, Paolo
NCT06371833: PRIMA EU Retrospective & Prospective

Recruiting
N/A
60
Europe
Shoulder Arthroplasy with PRIMA humeral stem
Limacorporate S.p.a, Iqvia Pty Ltd
Arthroplasty, Replacement, Shoulder
12/26
12/26
Packham, Iain
REGENETEN, NCT04450342: ™ Bioinductive Implant System in Full-thickness Tears

Terminated
N/A
119
Europe, Canada, US, RoW
Arthroscopic rotator cuff repair with REGENETEN™ Bioinductive Implant augmentation, Arthroscopic rotator cuff repair, Arthroscopic rotator cuff repair for revision surgery
Smith & Nephew, Inc.
Rotator Cuff Injuries
10/23
10/23
IMPACT, NCT05444465: Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

Recruiting
N/A
234
Europe, Canada, US, RoW
Isolated Bioinductive Repair, REGENETEN™ Bioinductive Implant, Completion and Repair
Smith & Nephew, Inc.
Rotator Cuff Injuries
08/26
06/28
NCT06371833: PRIMA EU Retrospective & Prospective

Recruiting
N/A
60
Europe
Shoulder Arthroplasy with PRIMA humeral stem
Limacorporate S.p.a, Iqvia Pty Ltd
Arthroplasty, Replacement, Shoulder
12/26
12/26
Kircher, Jörn
NCT06371833: PRIMA EU Retrospective & Prospective

Recruiting
N/A
60
Europe
Shoulder Arthroplasy with PRIMA humeral stem
Limacorporate S.p.a, Iqvia Pty Ltd
Arthroplasty, Replacement, Shoulder
12/26
12/26
Malhas, Amar
NCT06371833: PRIMA EU Retrospective & Prospective

Recruiting
N/A
60
Europe
Shoulder Arthroplasy with PRIMA humeral stem
Limacorporate S.p.a, Iqvia Pty Ltd
Arthroplasty, Replacement, Shoulder
12/26
12/26

Download Options